drugset / Trial / NCT00274859

Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer

NCT00274859 ↗

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as gemcitabine and oxaliplatin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving gemcitabine together with oxaliplatin works in treating patients with metastatic cancer who cannot receive anthracycline or taxane therapy.

Timeline

Start
2005-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — Intravenous
Subject Oxaliplatin Small molecule — Intravenous